• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES INTRACLUDE INTRA-AORTIC OCCLUSION CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES INTRACLUDE INTRA-AORTIC OCCLUSION CATHETER Back to Search Results
Model Number ICF100
Health Effect - Clinical Codes Unspecified Infection (1930); Renal Failure (2041); Respiratory Distress (2045); Multiple Organ Dysfunction Syndrome (3261)
Date of Event 06/01/2018
Type of Reportable Event Death
Additional Manufacturer Narrative
The clamp device is essential to occlude the aorta and provide the necessary cardiac isolation required to perform minimally invasive cardiac surgery procedures.If the balloon bursts during a procedure, the heart would fill and warm, the operative site may be obscured and the procedure may need to convert to an open procedure.In this case, after the balloon rupture, the surgery was finished in cold ventricular fibrillation.As per surgeon´s opinion, the death was probably not related with the device as per patient pre-operative conditions.The device was not returned for evaluation at this time.The root cause of the rupture remains indeterminable.If new information is received, a supplemental report will be submitted.The device history record (dhr) was not able to be reviewed as the device lot number was not provided.Edwards will continue to review and monitor all events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
 
Event or Problem Description
Edwards received notification that during a mitral valve replacement (mvr) surgery, the balloon of an intra-aortic occlusion catheter ruptured during use.After balloon rupture, the surgery was finished in cold ventricular fibrillation (bailout strategy).After extubation the patient was transfer to icu where the patient had to be re-intubated due to being adynamic, weak and ran into respiratory insufficiency.Brain damage showed no pathological finding.Patient had nosocomial infection that deteriorated developing renal failure.Patient passed away on pod+5 from multiple organ failure.This high-risk female patient had acute infective endocarditis and was in very critical condition on admission.As per surgeon´s opinion, the death was probably not related with the device as per patient pre-operative conditions.In mvr surgeries, consequences of balloon rupture imply de-airing challenge because low pressure with backflow of cardioplegia into lv through av occur.The surgeon and medical team are very experienced with the device (around 400 cases so far).Normal procedure includes: initial balloon volumen was 20ml, then adding additional volumen until device does not move.Target balloon pressure was 350 mmhg.At the time of this case, patient´s ct scan was not done regularly in all patients (contraindication in case of plaques, calcification) and they were not strict with limiting patients to 40mm aorta size (as per ifu) so it could be a bit bigger.
 
Additional Manufacturer Narrative
An engineering evaluation was completed and a manufacturing, supplier, design, ifu, and labeling defect were not confirmed.The trend was reviewed and found to be in control.No further action is required.The root cause cannot be determined at this time.Edwards will continue to review and monitor all events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
 
Additional Manufacturer Narrative
Corrected data: f10, h6.Reference capa-20-00141.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INTRACLUDE INTRA-AORTIC OCCLUSION CATHETER
Common Device Name
INTRA-AORTIC OCCLUSION CATHETER
Manufacturer (Section D)
EDWARDS LIFESCIENCES
one edwards way
irvine CA 92614
MDR Report Key8620026
Report Number3008500478-2019-00133
Device Sequence Number2211576
Product Code DXC
Combination Product (Y/N)N
Initial Reporter CountryGM
PMA/510(K) Number
K132175
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source foreign,health professional,u
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 04/24/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberICF100
Device Catalogue NumberICF100
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 04/24/2019
Supplement Date Received by Manufacturer06/21/2019
07/23/2020
Initial Report FDA Received Date05/17/2019
Supplement Report FDA Received Date06/24/2019
12/24/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Death; Hospitalization; Required Intervention;
-
-